Cancer Outcomes Seminar Series: Albert Wu, Center for Health Services and Outcomes Research, Johns Hopkins University
"Attack of the PROs – How PCOR is Subverting the Clinical Research"
Albert Wu, MD, Director, Center for Health Services and Outcomes Research, Director, PhD Program in Health Services Research & Policy, Director, Certificate Program in Quality, Patient Safety & Outcomes Research, Bloomberg School of Public Health, Johns Hopkins University
Weiping Zou, MD, PhD, The DeNancrede Endowed Chair, Professor of Surgery, Immunology and Biology, University of Michigan
Deepak Voora, MD, Assistant Professor of Medicine – Duke University Medical Center
Roel Vermeulen, PhD, Institute for Risk Assessment Sciences, Division of Environmental Epidemiology, Utrecht University, The Netherlands
Robert K. McGinty, MD, PhD, Damon Runyon Postdoctoral Fellow, The Pennsylvania State University
Jonathan Kagan, Ph.D., Harvard Medical School and Boston Children’s Hospital
The Quality of Decisions about Breast Reconstruction after Mastectomy
Peter Agre, M.D., Nobel Laureate in Chemistry, Bloomberg Distinguished Professor, Director of the Johns Hopkins Malaria Research Institute
The Role of Oncogenic BRAF (V600E) in Tumor Initiation, Cancer Progression and Response to Pathway-Targeted Therapy
UNC Lineberger Comprehensive Cancer Center
450 West Drive, Chapel Hill NC
Martin McMahon, PhD, Efim Guzik Distinguished Professor in Cancer Biology; Co-Leader, Developmental Therapeutics Program; and Professor In Residence, Department of Cellular and Molecular Pharmacology, University of California at San Francisco. Co-sponsored by UNC Lineberger Comprehensive Cancer Center and Duke Cancer Institute.